ACER THERAPEUTICS INC (ACER) Forecast, Price Target & Analyst Ratings
NASDAQ:ACER • US00444P1084
0.9 USD
+0.03 (+3.41%)
At close: Nov 8, 2023
0.8005 USD
-0.1 (-11.06%)
After Hours: 11/8/2023, 8:19:05 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ACER THERAPEUTICS INC (ACER).
Forecast Snapshot
Consensus Price Target
$1.53
+ 70.00% Upside
Next Earnings Forecast
Release DateMar 25, 2024
PeriodQ3 / 2023
EPS Estimate-$0.13
Revenue Estimate2.601M
ChartMill Buy Consensus
80.00%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$1.53
Upside
+ 70.00%
From current price of $0.90 to mean target of $1.53, Based on 8 analyst forecasts
Low
$1.52
Median
$1.53
High
$1.58
Price Target Revisions
1 Month
0.00%
3 Months
-86.36%
Price Target Summary
8 analysts have analysed ACER and the average price target is 1.53 USD. This implies a price increase of 70% is expected in the next year compared to the current price of 0.9.
The average price target has been revised downward by 86.36% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
80.00%
ACER was analyzed by 8 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about ACER.
In the previous month the buy percentage consensus was at a similar level.
ACER was analyzed by 8 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2023-09-05 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2023-09-01 | Roth MKM | Downgrade | Buy -> Neutral |
| 2023-09-01 | Roth Capital | Downgrade | Buy -> Neutral |
| 2023-03-28 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-20 | EF Hutton | Reiterate | Buy |
| 2022-02-02 | EF Hutton | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
Release DateMar 25, 2024
PeriodQ3 / 2023
EPS Estimate-$0.13
Revenue Estimate2.601M
Revenue Q2QN/A
EPS Q2Q58.87%
Number of Analysts4
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%
Next Earnings Summary
ACER is expected to report earnings on 3/25/2024. The consensus EPS estimate for the next earnings is -0.13 USD and the consensus revenue estimate is 2.60M USD.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.26M | -100.00% | 8.844M | 49.402M 458.59% | 112.14M 126.99% | 150.89M 34.56% | 173.65M 15.08% | 188.61M 8.62% | 200.55M 6.33% | 210.34M 4.88% | |||
| EBITDA YoY % growth | -29.84M -37.64% | -22.73M 23.83% | -15.877M 30.15% | N/A -54.61% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -29.9M -37.72% | -22.8M 23.75% | -15.948M 30.05% | -25.968M -54.34% | -15.091M 38.69% | 16.361M 208.41% | 70.62M 331.64% | 104.75M 48.33% | 124.16M 18.53% | 136.5M 9.94% | 146.06M 7.00% | 153.64M 5.19% | |
| Operating Margin | N/A | N/A | -1,265.75% | N/A | -170.64% | 33.12% | 62.97% | 69.42% | 71.50% | 72.37% | 72.83% | 73.04% | |
| EPS YoY % growth | -2.91 -18.78% | -2.06 29.21% | -0.88 57.28% | -1.51 -88.64% | -0.74 55.45% | 0.12 116.55% | 0.77 525.00% | N/A | N/A | N/A | N/A | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q3 / 23 | Q4 / 23 | |
|---|---|---|
| EPS Q2Q % growth | -0.13 58.87% | -0.08 85.83% |
| Revenue Q2Q % growth | 2.601M | 6.243M |
| EBITDA Q2Q % growth | N/A | N/A |
| EBIT Q2Q % growth | -3.41M 34.91% | -2.204M 58.12% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
35.01%
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
ACER THERAPEUTICS INC / ACER Forecast FAQ
What do analysts expect the price target to be for ACER THERAPEUTICS INC (ACER)?
8 analysts have analysed ACER and the average price target is 1.53 USD. This implies a price increase of 70% is expected in the next year compared to the current price of 0.9.
When does ACER THERAPEUTICS INC (ACER) report earnings?
ACER THERAPEUTICS INC (ACER) will report earnings on 2024-03-25, after the market close.
What are the consensus estimates for ACER stock next earnings?
The consensus EPS estimate for the next earnings of ACER THERAPEUTICS INC (ACER) is -0.13 USD and the consensus revenue estimate is 2.60M USD.
Can you provide the analyst count for ACER THERAPEUTICS INC stock?
The number of analysts covering ACER THERAPEUTICS INC (ACER) is 8.